Hyperbaric Oxygen Treatment in a Diabetic Rat Model Is Associated with a Decrease in Blood Glucose, Regression of Organ Damage and Improvement in Wound Healing

Sulistiana Prabowo, Maria Nataatmadja, Janto Poernomo Hadi, Irmawati Dikman, Fitri Handajani, Sihning E. J. Tehupuring, Iswahyudi Soetarso, Mohammad Guritno Suryokusumo, Aulanni’am Aulanni’am, Anita Herawati, Malcolm West

Biochemistry Laboratory, Faculty of Sciences, Brawijaya University, Malang, Indonesia.
Cardiovascular Research Group, Prince Charles Hospital, School of Medicine, University of Queensland, Brisbane, Australia.
Faculty of Medicine, Hang Tuah University, Surabaya, Indonesia.

DOI: 10.4236/health.2014.615228                

Abstract

Diabetes leads to widespread complications including pancreatic β-cell damage, nephropathy and impaired wound healing. Hyperbaric oxygen therapy (HBOT) has been shown to improve wound healing through induction of stem cell recruitment and the potential to inhibit progression of diabetic complications. We aimed to determine the efficacy of HBOT in wound healing and organ preservation in a diabetic rat model. Diabetes was induced in male Wistar rats (n = 10/group) using streptozotocin (20 mg/kg sc) daily for 3 days. A wound was inflicted on the skin over the back and the rats were given HBOT (2.3 ATA for 1 h/day) for 1, 3, 5, 7 or 10 days or were not treated. Blood glucose, pancreatic β-cell damage, diabetic nephropathy and wound healing progression were assessed. Diabetic rats not treated with HBOT had significantly higher blood glucose levels compared to controls (26.7 ± 3.3 mmol/L vs. 5.8 ± 0.4 mmol/L; P ≤ 0.05). This was associated with significant increase in the percentage of β-cell damage (72% ± 9% vs. 10% ± 2%; P ≤ 0.05) and diabetic nephropathy. HBOT for 3 days and longer in diabetic rats reduced hyperglycemia to control levels. Pancreatic β-cell damage was negligible in rats treated with HBOT for 5 days and longer while diabetic nephropathy was diminished in animals treated for 10 days. Similarly HBOT induced wound healing and accelerated epithelial closure from 5 days of HBOT. In summary, our findings show the efficacy of HBOT in this diabetic rat model. There was significant reduction of hyperglycemia and inhibition of diabetic complications in the form of preservation of pancreatic and kidney structure and accelerated wound healing.

Keywords

Diabetes, Hyperbaric Therapy, Wound, Pancreas, Kidney

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Danaei, G., et al. (2011) National, Regional, and Global Trends in Fasting Plasma Glucose and Diabetes Prevalence since 1980: Systematic Analysis of Health Examination Surveys and Epidemiological Studies with 370 Country-Years and 2.7 Million Participants. Lancet, 378, 31-40. http://dx.doi.org/10.1016/S0140-6736(11)60679-X
[2]	Onkamo, P., et al. (1999) Worldwide Increase in Incidence of Type I Diabetes—The Analysis of the Data on Published Incidence Trends. Diabetologia, 42, 1395-1403. http://dx.doi.org/10.1007/s001250051309
[3]	Gray, S.P. and Jandeleit-Dahm, K. (2014) The Pathobiology of Diabetic Vascular Complications—Cardiovascular and Kidney Disease. Journal of Molecular Medicine, 92, 441-452. http://dx.doi.org/10.1007/s00109-014-1146-1
[4]	Brem, H. and Tomic-Canic, M. (2007) Cellular and Molecular Basis of Wound Healing in Diabetes. Journal of Clinical Investigation, 117, 1219-1222. http://dx.doi.org/10.1172/JCI32169
[5]	Shaw, J.E., Sicree, R.A. and Zimmet, P.Z. (2010) Global Estimates of the Prevalence of Diabetes for 2010 and 2030. Diabetes Research and Clinical Practice, 87, 4-14. http://dx.doi.org/10.1016/j.diabres.2009.10.007
[6]	Cooper, M.E., et al. (2001) Mechanisms of Diabetic Vasculopathy: An Overview. American Journal of Hypertension, 14, 475-486. http://dx.doi.org/10.1016/S0895-7061(00)01323-6
[7]	Rahman, S., et al. (2007) Diabetes-Associated Macro-vasculopathy: Pathophysiology and Pathogenesis. Diabetes, Obesity and Metabolism, 9, 767-780. http://dx.doi.org/10.1111/j.1463-1326.2006.00655.x
[8]	Brownlee, M. (2001) Biochemistry and Molecular Cell Biology of Diabetic Complications. Nature, 414, 813-820. http://dx.doi.org/10.1038/414813a
[9]	Kowluru, R.A. and Chan, P.S. (2007) Oxidative Stress and Diabetic Retinopathy. Experimental Diabetes Research, 2007, 43603.
[10]	Buras, J.A., et al. (2000) Hyperbaric Oxygen Downregulates ICAM-1 Expression Induced by Hypoxia and Hypogly-cemia: The Role of NOS. American Journal of Physiology—Cell Physiology, 278, C292-C302.
[11]	Hink, J., Thom, S.R., Simonsen, U., Rubin, I. and Jansen, E. (2006) Vascular Reactivity and Endothelial NOS Activity in Rat Thoracic Aorta during and after Hyperbaric Oxygen Exposure. American Journal of Physiology-Heart and Circulatory Physiology, 291, H1988-H1998. http://dx.doi.org/10.1152/ajpheart.00145.2006
[12]	Matsunami, T., Sato, Y., Hasegawa, Y., Ariga, S., Kashimura, H., Sato, T. and Yukawa, M. (2011) Enhancement of Reactive Oxygen Species and Induction of Apoptosis in Streptozotocin-Induced Diabetic Rats under Hyperbaric Oxygen Exposure. International Journal of Clinical and Experimental Pathology, 4, 255-266.
[13]	Wolff, S.P., Jiang, Z.Y. and Hunt, J.V. (1991) Protein Glycation and Oxidative Stress in Diabetes Mellitus and Ageing. Free Radical Biology and Medicine, 10, 339-352. http://dx.doi.org/10.1016/0891-5849(91)90040-A
[14]	Reiber, G.E., Vileikyte, L., Boyko, E.J., del Aguila, M., Smith, D.G., Lavery, L.A. and Boulton, A.J. (1999) Causal Pathways for Incident Lower-Extremity Ulcers in Patients with Diabetes from Two Settings. Diabetes Care, 22, 157-162. http://dx.doi.org/10.2337/diacare.22.1.157
[15]	Aguayo-Mazzucato, C. and Bonner-Weir, S. (2010) Stem Cell Therapy for Type 1 Diabetes Mellitus. Nature Reviews Endocrinology, 6, 139-148. http://dx.doi.org/10.1038/nrendo.2009.274
[16]	Couri, C.E. and Voltarelli, J.C. (2008) Potential Role of Stem Cell Therapy in Type 1 Diabetes Mellitus. Arquivos Brasileiros de Endocrinologia & Metabologia, 52, 407-415. http://dx.doi.org/10.1590/S0004-27302008000200029
[17]	Liu, Z.J. and Velazquez, O.C. (2008) Hyperoxia, Endothelial Progenitor Cell Mobilization, and Diabetic Wound Healing. Antioxidants & Redox Signaling, 10, 1869-1882. http://dx.doi.org/10.1089/ars.2008.2121
[18]	Broussard, C.L. (2004) Hyperbaric Oxygenation and Wound Healing. Journal of Vascular Nursing, 22, 42-48. http://dx.doi.org/10.1016/j.jvn.2004.03.001
[19]	Hunt, T.K., Burke, J., Barbul, A. and Gimbel, M.L. (1999) Wound Healing. Science, 284, 1775.
[20]	Boykin, J.V. (2002) How Hyperbaric Oxygen Therapy Helps Heal Chronic Wounds. Nursing, 32, 24. http://dx.doi.org/10.1097/00152193-200206000-00017
[21]	Thom, S.R. (2011) Hyperbaric Oxygen: Its Mechanisms and Efficacy. Plastic and Reconstructive Surgery, 127, 131S-141S. http://dx.doi.org/10.1097/PRS.0b013e3181fbe2bf
[22]	Falanga, V. (2005) Wound Healing and Its Impairment in the Diabetic Foot. Lancet, 366, 1736-1743. http://dx.doi.org/10.1016/S0140-6736(05)67700-8
[23]	Duzgun, A.P., Satir, H.Z., Ozozan, O., Saylam, B., Kulah, B. and Coskun, F. (2008) Effect of Hyperbaric Oxygen Therapy on Healing of Diabetic Foot Ulcers. The Journal of Foot and Ankle Surgery: Official Publication of the American College of Foot and Ankle Surgeons, 47, 515-519. http://dx.doi.org/10.1053/j.jfas.2008.08.002
[24]	Gallagher, K.A., Liu, Z.J., Xiao, M., Chen, H.Y., Goldstein, L.J., Buerk, D.G., Nedeau, A., Thom, S.R. and Velazquez, O.C. (2007) Diabetic Impairments in NO-Mediated Endothelial Progenitor Cell Mobilization and Homing Are Reversed by Hyperoxia and SDF-1α. Journal of Clinical Investigation, 117, 1249-1259. http://dx.doi.org/10.1172/JCI29710
[25]	Velazquez, O.C. (2007) Angiogenesis and Vasculogenesis: Inducing the Growth of New Blood Vessels and Wound Healing by Stimulation of Bone Marrow-Derived Progenitor Cell Mobilization and Homing. Journal of Vascular Surgery: Official Publication, the Society for Vascular Surgery [and] International Society for Cardiovascular Surgery, North American Chapter, 45, A39-A47.
[26]	Thom, S.R., Milovanova, T.N., Yang, M., Bhopale, V.M., Sorokina, E.M., Uzun, G., Malay, D.S., Troiano, M.A., Hardy, K.R., Lambert, D.S., Logue, C.J. and Margolis, D.J. (2011) Vasculogenic Stem Cell Mobilization and Wound Recruitment in Diabetic Patients: Increased Cell Number and Intracellular Regulatory Protein Content Associated with Hyperbaric Oxygen Therapy. Wound Repair and Regeneration: Official Publication of the Wound Healing Society [and] the European Tissue Repair Society, 19, 149-161.
[27]	Braiman-Wiksman, L., Solomonik, I., Spira, R. and Tennenbaum, T. (2007) Novel Insights into Wound Healing Sequence of Events. Toxicologic Pathology, 35, 767-779. http://dx.doi.org/10.1080/01926230701584189
[28]	In’t Veld, P. (2011) Insulitis in Human Type 1 Diabetes: The Quest for an Elusive Lesion. Islets, 3, 131-138. http://dx.doi.org/10.4161/isl.3.4.15728
[29]	Tervaert, T.W., Mooyaart, A.L., Amann, K., Cohen, A.H., Cook, H.T., Drachenberg, C.B., Ferrario, F., et al. (2010) Pathologic Classification of Diabetic Nephropathy. Journal of the American Society of Nephrology, 21, 556-563. http://dx.doi.org/10.1681/ASN.2010010010
[30]	Braiman-Wiksman, L., Solomonik, I., Spira, R. and Tennenbaum, T. (2007) Novel Insights into Wound Healing Sequence of Events. Toxicologic Pathology, 35, 767-779. http://dx.doi.org/10.1080/01926230701584189
[31]	Lee, J.Y., Lee, F.Y., Huo, T.I., Wang, S.S., Huang, H.C., Lin, H.C., Chuang, C.L. and Lee, S.D. (2014) Diabetes Enhances the Intrahepatic Vascular Response to Endothelin-1 in Cirrhotic Rats: Association with the ET Receptor and pERK Up-Regulation. Liver International, Early View. http://dx.doi.org/10.1111/liv.12527
[32]	Oliveira, P.A., Oliveira, A.M.S., Pablos, A.B., Costa, F.O., Borges Silva, G.A., dos Santos, J.N. and Cury, P.R. (2012) Influence of Hyperbaric Oxygen Therapy on Peri-Implant Bone Healing in Rats with Alloxan-Induced Diabetes. Journal of Clinical Periodontology, 39, 879-886. http://dx.doi.org/10.1111/j.1600-051X.2012.01922.x
[33]	Ueno, T., Omi, T., Uchida, E., Yokota, H. and Kawana, S. (2014) Evaluation of Hyperbaric Oxygen Therapy for Chronic Wounds. Journal of Nippon Medical School, 81, 4-11. http://dx.doi.org/10.1272/jnms.81.4
[34]	Stoekenbroek, R.M., Santema, T.B., Legemate, D.A., Ubbink, D.T., van den Brink, A. and Koelemay, M.J.W. (2014) Hyperbaric Oxygen for the Treatment of Diabetic Foot Ulcers: A Systematic Review. European Journal of Vascular & Endovascular Surgery, 47, 647-655. http://dx.doi.org/10.1016/j.ejvs.2014.03.005
[35]	Liu, R., Li, L., Yang, M.L., Boden, G. and Yang, G.Y. (2013) Systematic Review of the Effectiveness of Hyperbaric Oxygenation Therapy in the Management of Chronic Diabetic Foot Ulcers. Mayo Clinic Proceedings, 88, 166-175. http://dx.doi.org/10.1016/j.mayocp.2012.10.021
[36]	Kranke, P., Bennett, M.H., Martyn-St James, M., Schnabel, A. and Debus, S.E. (2012) Hyperbaric Oxygen Therapy for Chronic Wounds. Cochrane Database of Systematic Reviews, 4, Article ID: CD004123.